Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P01178 (
oxytocin
)
15,767
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Hypothalamic neuropeptides play essential roles in regulating energy and body weight balance. Energy imbalance and obesity have been linked to hypothalamic signaling defects in regulating neuropeptide genes; however, it is unknown whether dysregulation of neuropeptide exocytosis could be critically involved. This study discovered that synaptotagmin-4, an atypical modulator of synaptic exocytosis, is expressed most abundantly in
oxytocin
neurons of the hypothalamus.
Synaptotagmin-4
negatively regulates
oxytocin
exocytosis, and dietary obesity is associated with increased vesicle binding of synaptotagmin-4 and thus enhanced negative regulation of
oxytocin
release. Overexpressing synaptotagmin-4 in hypothalamic
oxytocin
neurons and centrally antagonizing
oxytocin
in mice are similarly obesogenic.
Synaptotagmin-4
inhibition prevents against dietary obesity by normalizing
oxytocin
release and energy balance under chronic nutritional excess. In conclusion, the negative regulation of synaptotagmin-4 on
oxytocin
release represents a hypothalamic basis of neuropeptide exocytosis in controlling obesity and related diseases.
...
PMID:Neuropeptide exocytosis involving synaptotagmin-4 and oxytocin in hypothalamic programming of body weight and energy balance. 2131 51